DE3765157D1 - Verfahren zur herstellung von macrolid-derivaten. - Google Patents

Verfahren zur herstellung von macrolid-derivaten.

Info

Publication number
DE3765157D1
DE3765157D1 DE8787302099T DE3765157T DE3765157D1 DE 3765157 D1 DE3765157 D1 DE 3765157D1 DE 8787302099 T DE8787302099 T DE 8787302099T DE 3765157 T DE3765157 T DE 3765157T DE 3765157 D1 DE3765157 D1 DE 3765157D1
Authority
DE
Germany
Prior art keywords
compound
formula
producing
macrolid
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787302099T
Other languages
English (en)
Inventor
Martin Todd
Mark A Haxell
Gordon C Lawrence
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DE3765157D1 publication Critical patent/DE3765157D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/445—The saccharide radical is condensed with a heterocyclic radical, e.g. everninomycin, papulacandin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Glass Compositions (AREA)
  • Pyrrole Compounds (AREA)
DE8787302099T 1986-03-12 1987-03-11 Verfahren zur herstellung von macrolid-derivaten. Expired - Fee Related DE3765157D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868606120A GB8606120D0 (en) 1986-03-12 1986-03-12 Process

Publications (1)

Publication Number Publication Date
DE3765157D1 true DE3765157D1 (de) 1990-10-31

Family

ID=10594470

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787302099T Expired - Fee Related DE3765157D1 (de) 1986-03-12 1987-03-11 Verfahren zur herstellung von macrolid-derivaten.

Country Status (10)

Country Link
US (1) US5378617A (de)
EP (1) EP0241147B1 (de)
JP (1) JPH07106155B2 (de)
AT (1) ATE56975T1 (de)
CA (1) CA1319636C (de)
DE (1) DE3765157D1 (de)
DK (1) DK165124C (de)
ES (1) ES2029832T3 (de)
GB (1) GB8606120D0 (de)
IE (1) IE60058B1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
US5840704A (en) * 1986-07-16 1998-11-24 Pfizer Inc. Antiparasitic agents and process for their preparation
US5212322A (en) * 1986-12-11 1993-05-18 Sankyo Company, Limited Macrolide compounds, their preparation and their use
AR243528A1 (es) * 1986-12-11 1993-08-31 Sankyo Co Procedimiento para preparar compuestos de macrolida y un procedimiento para producir con los mismos una composicion parasiticida.
EP0284176B1 (de) * 1987-01-23 1993-08-25 Pfizer Inc. Verfahren zur Herstellung von Avermectinen und die verwendeten Kulturen
US5525506A (en) * 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5234831A (en) * 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
IN167980B (de) * 1987-01-23 1991-01-19 Pfizer
US5238848A (en) * 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
PT88952B (pt) * 1987-11-09 1993-02-26 Pfizer Processo para a preparacao de avermectinas etiladas
GB8726730D0 (en) * 1987-11-14 1987-12-16 Pfizer Ltd Antiparasitic agents
JP2792856B2 (ja) * 1987-12-28 1998-09-03 山之内製薬株式会社 抗生物質の製造方法
GB8815967D0 (en) * 1988-07-05 1988-08-10 Pfizer Ltd Antiparasitic agents
US6103504A (en) * 1992-03-25 2000-08-15 Pfizer Inc. Process for production of avermectins and cultures therefor
CN104193760B (zh) * 2014-08-29 2016-11-30 宁夏泰瑞制药股份有限公司 一种利用奈马菌素发酵液提取奈马菌素粗品的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (de) * 1972-06-08 1974-02-08
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
DE2909071A1 (de) * 1979-03-08 1980-09-11 Schmuecking Carl Guenther Epikutantestpflaster
IT1182857B (it) * 1984-09-14 1987-10-05 Glaxo Group Ltd Composti antibiotici, composizioni antiparassitarie che li contengono e procedimento per prepararli ed applicarli

Also Published As

Publication number Publication date
US5378617A (en) 1995-01-03
ATE56975T1 (de) 1990-10-15
JPH07106155B2 (ja) 1995-11-15
CA1319636C (en) 1993-06-29
DK125387D0 (da) 1987-03-11
GB8606120D0 (en) 1986-04-16
IE60058B1 (en) 1994-05-18
DK125387A (da) 1987-09-13
DK165124C (da) 1993-03-01
JPS62272986A (ja) 1987-11-27
DK165124B (da) 1992-10-12
ES2029832T3 (es) 1992-10-01
EP0241147B1 (de) 1990-09-26
IE870626L (en) 1987-09-12
EP0241147A1 (de) 1987-10-14

Similar Documents

Publication Publication Date Title
DE3765157D1 (de) Verfahren zur herstellung von macrolid-derivaten.
DE3687946D1 (de) Verfahren zur herstellung der 2-keto-l-gulonsaeure.
ATE124458T1 (de) Verfahren zur herstellung von bis-homo-gamma- linolensäure.
ATE118496T1 (de) Verfahren zur herstellung von 4-o- dopaminphosphaten und dopaminderivate.
ATE155172T1 (de) Verfahren zur herstellung einer mehrfach ungesättigten fettsäure des omega 9 typs
DE3680938D1 (de) Verfahren zur herstellung von substituierten 3-chinolincarbonsaeuren.
DE3882453D1 (de) Verfahren zur herstellung von ibuprofen.
DE68927103D1 (de) Verfahren zur herstellung von gamma- und delta-lactonen
DE68906904D1 (de) Verfahren zur herstellung von optisch aktiven 2-arylalkansaeuren.
DE3785023D1 (de) Verfahren zur herstellung von arachidonsaeure.
ATE67788T1 (de) Herstellung von derivaten von a-21978c.
ATE104268T1 (de) Verfahren zur herstellung eines alphaketocarbons|ureester.
ATE177091T1 (de) Chinasäurederivate und verfahren zur herstellung von chinasäurederivaten
ATE116636T1 (de) Verfahren zur herstellung von 2,6- dichlordiphenylaminessigsäurederivaten.
DE3579663D1 (de) Verfahren zur herstellung aromatisch substituierter l-aminosaeuren.
DE68912236D1 (de) Verfahren zur Herstellung von hochgradig ungesättigten Fettsäuren.
ATE150003T1 (de) Verfahren zur herstellung von l-(-)-carnitin aus abfallprodukten mit entgegengesetzter konfiguration
ATA166985A (de) Verfahren zur herstellung von 7-amino-3alkoxymethyl-3-cephem-4-carbonsaeuren
ATE139989T1 (de) Verfahren zur herstellung von niedrigem alkyl-2- oxo-l-gulonat
DE69005309D1 (de) Verfahren zur herstellung von peroxykarbonsäuren unter verwendung eines enzymkatalysators.
ATE127470T1 (de) Verfahren zur herstellung von phosphatidylcholinderivaten.
ATE233751T1 (de) Verfahren zur herstellung und zwischenprodukt der 2-(10,11-dihydro-10-oxodibenzo(b,f)thiepin-2-yl - propionsäure
ATE135369T1 (de) Chemisches verfahren zur herstellung des antibiotikums l 17392 (deglukoteicoplanin) und dessen salze
DE3779403D1 (de) Enzymatisches verfahren zur herstellung von 3-substituierten cephalosporinen.
DE69015499D1 (de) Verfahren zur Herstellung von Castanosperminestern.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee